Regulatory and signaling properties of the Vav family

Molecular and Cellular Biology

Volumn 20, Issue 5, 2000, Pages 1461-1477

  Bustelo, Xosé R ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALPONIN; GUANOSINE TRIPHOSPHATE; M PROTEIN; MEMBRANE RECEPTOR; RAC PROTEIN; RAS PROTEIN;

CATALYSIS; ENZYME ACTIVITY; GENETIC ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; SIGNAL TRANSDUCTION;

EID: 0033974061     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.5.1461-1477.2000     Document Type: Short Survey

References (172)

1. vav, in human hematopoietic cells. J. Biol. Chem. 267:18021-18025.
2. Allen, K. M., J. G. Gleeson, S. Bagrodia, M. W. Partington, J. C. MacMillan, R. A. Cerione, J. C. Mulley, and C. A. Walsh. 1998. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat. Genet. 20:25-30.
3. August, A., S. Gibson, Y. Kawakami, T. Kawakami, G. B. Mills, and B. Dupont. 1994. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc. Natl. Acad. Sci. USA 91:9347-9351.
4. Avraham, A., S. Jung, Y. Samuels, R. Seger, and Y. Ben-Neriah. 1998. Costimulation-dependent activation of a JNK-kinase in T lymphocytes. Eur. J. Immunol. 28:2320-2330.
5. Billadeau, D. D., K. M. Brumbaugh, C. J. Dick, R. A. Schoon, X. R. Bustelo, and P. J. Leibson. 1998. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J. Exp. Med. 188:549-559.
6. Bogatcheva, N. V., and N. B. Gusev. 1995. Interaction of smooth muscle calponin with phospholipids. FEBS Lett. 371:123-126.
7. Boguski, M. S., and F. McCormick. 1993. Proteins regulating Ras and its relatives. Nature 366:643-654.
8. Bubeck Wardenburg, J., R. Pappu, J. Y. Bu, B. Mayer, J. Chernoff, D. Straus, and A. C. Chan. 1998. Regulation of PAK activation and the T cell cytoskeleton by the linker protein SLP-76. Immunity 9:607-616.
9. Bustelo, X. R. 1996. The VAV family of signal transduction molecules. Crit. Rev. Oncog. 7:65-88.
10. Bustelo, X. R., and M. Barbacid. 1992. Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science 256:1196-1199.
11. Bustelo, X. R., P. Crespo, M. Lopez-Barahona, J. S. Gutkind, and M. Barbacid. 1997. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation. Oncogene 15:2511-2520.
12. Bustelo, X. R., J. A. Ledbetter, and M. Barbacid. 1992. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature 356:68-71.
13. Bustelo, X. R., K. L. Suen, K. Leftheris, C. A. Meyers, and M. Barbacid. 1994. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor. Oncogene 9:2405-2413.
14. Carugo, K. D., S. Banuelos, and M. Saraste. 1997. Crystal structure of a calponin homology domain. Nat. Struct. Biol. 4:175-179.
15. Castresana, J., and M. Saraste. 1995. Does Vav bind to F-actin through a CH domain? FEBS Lett. 374:149-151.
16. Cerione, R. A., and Y. Zheng. 1996. The Db1 family of oncogenes. Curr. Opin. Cell Biol. 8:216-222.
17. Chan, A. C., T. A. Kadlecek, M. E. Elder, A. H. Filipovich, W. L. Kuo, M. Iwashima, T. G. Parslow, and A. Weiss. 1994. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 264:1599-1601.
18. Chang, J. H., J. C. Pratt, S. Sawasdikosol, R. Kapeller, and S. J. Burakoff. 1998. The small GTP-binding protein Rho potentiates AP-1 transcription in T cells. Mol. Cell. Biol. 18:4986-4993.
19. Chardin, P., S. Paris, B. Antonny, S. Robineau, S. Beraud-Dufour, C. L. Jackson, and M. Chabre. 1996. A human exchange factor for ARF contains Sec7-and pleckstrin-homology domains. Nature 384:481-484.
20. Chu, D. H., C. T. Morita, and A. Weiss. 1998. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol. Rev. 165: 167-180.
21. vav, in platelets. J. Biol. Chem. 271:7544-7550.
22. Cichowski, K., M. J. Orsini, and L. F. Brass. 1999. PAR1 activation initiates integrin engagement and outside-in signalling in megakaryoblastic CHRF-288 cells. Biochim. Biophys. Acta. 1450:265-276.
23. Clevenger, C. V., W. Ngo, D. L. Sokol, S. M. Luger, and A. M. Gewirtz. 1995. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J. Biol. Chem. 270:13246-13253.
24. Coppola, J., S. Bryant, T. Koda, D. Conway, and M. Barbacid. 1991. Mechanism of activation of the vav protooncogene. Cell Growth Differ. 2:95-105.
25. Costello, P. S., A. E. Walters, P. J. Mee, M. Turner, L. F. Reynolds, A. Prisco, N. Sarner, R. Zamoyska, and V. L. Tybulewicz. 1999. The Rho-family GTP exchange Factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-κB pathways. Proc. Natl. Acad. Sci. USA 96:3035-3040.
26. Crespo, P., X. R. Bustelo, D. S. Aaronson, O. A. Coso, M. Lopez-Barahona, M. Barbacid, and J. S. Gutkind. 1996. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene 13:455-460.
27. Crespo, P., K. E. Schuebel, A. A. Ostrom, J. S. Gutkind, and X. R. Bustelo. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385:169-172.
28. Deckert, M., S. Tartare-Deckert, C. Couture, T. Mustelin, and A. Altman. 1996. Functional and physical interactions of Syk family kinases with the vav proto-oncogene product. Immunity 5:591-604.
29. De Sepulveda, P., K. Okkenhaug, J. L. Rose, R. G. Hawley, P. Dubreuil, and R. Rottapel. 1999. Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. EMBO J. 18:904-915.
30. Doody, G. M., L. B. Justement, C. C. Delibrias, R. J. Matthews, J. Lin, M. L. Thomas, and D. T. Fearon. 1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269:242-244.
31. Dorsch, M., P. D. Fan, J. Bogenberger, and S. P. Goff. 1995. TPO and IL-3 induce overlapping but distinct protein tyrosine phosphorylation in a myeloid precursor cell line. Biochem. Biophys. Res. Commun. 214:424-431.
32. Dorsch, M., P. D. Fan, N. N. Danial, P. B. Rothman, and S. P. Goff. 1997. The thrombopoietin receptor can mediate proliferation without activation of the Jak-STAT pathway. J. Exp. Med. 186:1947-1955.
33. Dosil, M., S. Wang, and I. R. Lemischka. 1993. Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells. Mol. Cell. Biol. 13:6572-6585.
34. Evans, G. A., O. M. Howard, R. Erwin, and W. L. Farrar. 1993. Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck. Biochem. J. 294:339-342.
35. Fang, N., and G. A. Koretzky. 1999. SLP-76 and Vav function in separate, but overlapping pathways to augment interleukin-2 promoter activity. J. Biol. Chem. 274:16206-16212.
36. Finco, T. S., T. Kadlecek, W. Zhang, L. E. Samelson, and A. Weiss. 1998. LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway. Immunity 9:617-626.
37. Fischer, K. D., Y. Y. Kong, H. Nishina, K. Tedford, L. E. Marengere, I. Kozieradzki, T. Sasaki, M. Starr, G. Chan, S. Gardener, M. P. Nghiem, D. Bouchard, M. Barbacid, A. Bernstein, and J. M. Penninger. 1998. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 8:554-562.
38. Fischer, K. D., K. Tedford, and J. M. Penninger. 1998. Vav links antigen-receptor signaling to the actin cytoskeleton. Semin. Immunol. 10:317-327.
39. Fischer, K. D., A. Zmuldzinas, S. Gardner, M. Barbacid, A. Bernstein, and C. Guidos. 1995. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes. Nature 374:474-477.
40. Fritz, G., I. Just, and B. Kaina. 1999. Rho GTPases are over-expressed in human tumors. Int. J. Cancer 81:682-687.
41. Fu, C., C. W. Turck, T. Kurosaki, and A. C. Chan. 1998. BLNK: a central linker protein in B cell activation. Immunity 9:93-103.
42. Fujii, T., K. Yamana, Y. Ogoma, and Y. Kondo. 1995. Interaction of calponin with phospholipids. J. Biochem. (Tokyo) 117:999-1003.
43. Fujimoto, M., J. C. Poe, M. Inaoki, and T. F. Tedder. 1998. CD19 regulates B lymphocyte responses to transmembrane signals. Semin. Immunol. 10: 267-277.
44. Fujimoto, M., J. C. Poe, P. J. Jansen, S. Sato, and T. F. Tedder. 1999. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J. Immunol. 162:7088-7094.
45. Fukuhara, S., C. Murga, M. Zohar, T. Igishi, and J. S. Gutkind. 1999. A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho. J. Biol. Chem. 274:5868-5879.
46. Galandrini, R., G. Palmieri, M. Piccoli, L. Frati, and A. Santoni. 1999. Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity. J. Immunol. 162:3148-3152.
47. Geng, Y., E. Gulbins, A. Altman, and M. Lotz. 1994. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc. Natl. Acad. Sci. USA 91:8602-8606.
48. Germani, A., F. Romero, M. Houlard, J. Camonis, S. Gisselbrecht, S. Fischer, and N. Varin-Blank. 1999. hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways. Mol. Cell. Biol. 19:3798-3807.
49. Gringhuis, S. I., L. F. de Leij, P. J. Coffer, and E. Vellenga. 1998. Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Rac1 in human mature T lymphocytes. Mol. Cell. Biol. 18:1725-1735.
50. Groysman, M., M. Nagano, B. Shaanan, and S. Katzav. 1998. Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation. Oncogene 17:1597-1606.
51. Gulbranson-Judge, A., V. L. Tybulewicz, A. E. Walters, K. M. Toellner, I. C. MacLennan, and M. Turner. 1999. Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help. Eur. J. Immunol. 29:477-487.
52. Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509-514.
53. Han, J., B. Das, W. Wei, L. Van Aelst, R. D. Mosteller, R. Khosravi-Far, J. K. Westwick, C. J. Der, and D. Broek. 1997. Lck regulates Vav activation of members of the Rho family of GTPases. Mol. Cell. Biol. 17:1346-1353.
54. Han, J., K. Luby-Phelps, B. Das, X. Shu, Y. Xia, R. D. Mosteller, U. M. Krishna, J. R. Falck, M. A. White, and D. Broek. 1998. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 279:558-560.
55. Henning, S. W., R. Galandrini, A. Hall, and D. A. Cantrell. 1997. The GTPase Rho has a critical regulatory role in thymus development. EMBO J. 16:2397-2407.
56. Henske, E. P., M. P. Short, S. Jozwiak, C. M. Bovey, S. Ramlakhan, J. L. Haines, and D. J. Kwiatkowski. 1995. Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1. Ann. Hum. Genet. 59: 25-37.
57. Hirasawa, N., A. Scharenberg, H. Yamamura, M. A. Beaven, and J. P. Kinel. 1995. A requirement for Syk in the activation of the microtubule-associated protein kinase/phospholipase A2 pathway by Fc epsilon R1 is not shared by a G protein-coupled receptor. J. Biol. Chem. 270:10960-10967.
58. Holsinger, L. J., I. A. Graef, W. Swat, T. Chi, D. M. Bautista, L. Davidson, R. S. Lewis, F. W. Alt, and G. R. Crabtree. 1998. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8:563-572.
59. Holsinger, L. J., D. M. Spencer, D. J. Austin, S. L. Schreiber, and G. R. Crabtree. 1995. Signal transduction in T lymphocytes using a conditional allele of Sos. Proc. Natl. Acad. Sci. USA 92:9810-9814.
60. Ihle, J. N. 1995. The Janus protein tyrosine kinases in hematopoietic cytokine signaling. Semin. Immunol. 7:247-254.
61. Ishiai, M., M. Kurosaki, R. Pappu, K. Okawa, I. Ronko, C. Fu, M. Shibata, A. Iwamatsu, A. C. Chan, and T. Kurosaki. 1999. BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells. Immunity 10:117-125.
62. Joazeiro, C. A., S. S. Wing, H. Huang, J. D. Leverson, T. Hunter, and Y. C. Liu. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286:309-312.
63. Johansen, F. E., and R. Prywes. 1995. Serum response factor: transcriptional regulation of genes induced by growth factors and differentiation. Biochim. Biophys. Acta 1242:1-10.
64. Kantor, A. B., A. M. Stall, S. Adams, and L. A. Herzenberg. 1992. Differential development of progenitor activity for three B-cell lineages. Proc. Natl. Acad. Sci. USA 89:3320-3324.
65. Katzav, S., J. L. Cleveland, H. E. Heslop, and D. Pulido. 1991. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol. Cell. Biol. 11:1912-1920.
66. Katzav, S., D. Martin-Zanca, and M. Barbacid. 1989. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8:2283-2290.
67. Katzav, S., M. Sutherland, G. Packham, T. Yi, and A. Weiss. 1994. The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. J. Biol. Chem. 269:32579-32585.
68. Khosravi-Far, R., M. Chrzanowska-Wodnicka, P. A. Solski, A. Eva, K. Burridge, and C. J. Der. 1994. Db1 and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol. Cell. Biol. 14:6848-6857.
69. Kiener, P. A., B. M. Rankin, A. L. Burkhardt, G. L. Schieven, L. K. Gilliland, R. B. Rowley, J. B. Bolen, and J. A. Ledbetter. 1993. Cross-linking of Fc gamma receptor I (Fc gamma RI) and receptor II (Fc gamma RII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase. J. Biol. Chem. 268:24442-24448.
70. Kim, H. H., M. Tharayil, and C. E. Rudd. 1998. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. J. Biol. Chem. 273:296-301.
71. Min. Proc. Natl. Acad. Sci. USA 96:4826-4831.
72. Kong, Y. Y., K. D. Fischer, M. F. Bachmann, S. Mariathasan, I. Kozieradzki, M. P. Nghiem, D. Bouchard, A. Bernstein, P. S. Ohashi, and J. M. Penninger. 1998. Vav regulates peptide-specific apoptosis in thymocytes. J. Exp. Med. 188:2099-2111.
73. Kon-Kozlowski, M., G. Pani, T. Pawson, and K. A. Siminovitch. 1996. The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells. J. Biol. Chem. 271:3856-3862.
74. 13. Science 280:2109-2111.
75. Kranewitter, W. J., and M. Gimona. 1999. N-terminally truncated Vav induces the formation of depolymerization-resistant actin filaments in NIH 3T3 cells. FEBS Lett. 455:123-129.
76. Krumenacker, J. S., D. W. Montgomery, D. J. Buckley, P. W. Gout, and A. R. Buckley. 1998. Prolactin receptor signaling: shared components with the T-cell antigen receptor in Nb2 lymphoma cells. Endocrine 9:313-320.
77. Kuhne, M. R., G. K. Ku, and A. Weiss. A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation. J. Biol. Chem., in press.
78. Lee, I. S., Y. Liu, M. Narazaki, M. Hibi, T. Kishimoto, and T. Taga. 1997. Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6. FEBS Lett. 401:133-137.
79. Leibson, P. J. 1997. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6:655-661.
80. Levkowitz, G., H. Waterman, E. Zamir, Z. Kam, S. Oved, W. Y. Langdon, L. Beguinot, B. Geiger, and Y. Yarden. 1998. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12:3663-3674.
81. Li, X., D. Sandoval, L. Freeberg, and R. H. Carter. 1997. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig. J. Immunol. 158:5649-5657.
82. Lopez-Lago, M., H. Lee, C. Cruz, N. Movilla, and X. R. Bustelo. 2000. Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav. Mol. Cell. Biol. 20:1678-1691.
83. Ma, A. D., A. Metjian, S. Bagrodia, S. Taylor, and C. S. Abrams. 1998. Cytoskeletal reorganization by G protein-coupled receptors is dependent on phosphoinositide 3-kinase gamma, a Rac guanosine exchange factor, and Rac. Mol. Cell. Biol. 18:4744-4751.
84. Machide, M., H. Mano, and K. Todokoro. 1995. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain. Oncogene 11:619-625.
85. Marengere, L. E., C. Mirtsos, I. Kozieradzki, A. Veillette, T. W. Mak, and J. M. Penninger. 1997. Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells. J. Immunol. 159:70-76.
86. Margolis, B., P. Hu, S. Katzav, W. Li, J. M. Oliver, A. Ullrich, A. Weiss, and J. Schlessinger. 1992. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature 356:71-74.
87. Marshall, C. J. 1996. Ras effectors. Curr. Opin. Cell. Biol. 8:197-204.
88. Martinerie, C., L. A. Cannizzaro, C. M. Croce, K. Huebner, S. Katzav, and M. Barbacid. 1990. The human VAV proto-oncogene maps to chromosome region 19p12-19p13.2. Hum. Genet. 86:65-68.
89. Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J. 14:257-265.
90. Melamed, I., H. Patel, C. Brodie, and E. W. Gelfand. 1999. Activation of Vav and Ras through the nerve growth factor and B cell receptors by different kinases. Cell. Immunol. 191:83-89.
91. Meng, W., S. Sawasdikosol, S. J. Burakoff, and M. J. Eck. 1999. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature 398:84-90.
92. Michel, F., L. Grimaud, L. Tuosto, and O. Acuto. 1998 Fyn and ZAP-70 are required for Vav phosphorylation in T cells stimulated by antigen-presenting cells. J. Biol. Chem. 273:31932-31938.
93. Michiels, F., J. C. Stam, P. L. Hordijk, R. A. van der Kammen, L. Ruuls-Van Stalle, C. A. Feltkamp, and J. G. Collard. 1997. Regulated membrane localization of Tiaml, mediated by the NH2-terminal pleckstrin homology domain, is required for Rac-dependent membrane ruffling and c-Jun NH2-terminal kinase activation. J. Cell. Biol. 137:387-398.
94. Miranti, C. K., L. Leng, P. Maschberger, J. S. Brugge, and S. J. Shattil. 1998. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1. Curr. Biol. 8:1289-1299.
95. Miura, O., Y. Miura, N. Nakamura, F. W. Quelle, B. A. Witthuhn, J. N. Ihle, and N. Aoki. 1994. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood 84:4135-4141.
96. Montaner, S., R. Perona, L. Saniger, and J. C. Lacal. 1999. Activation of serum response factor by RhoA is mediated by the nuclear factor-kappaB and C/EBP transcription factors. J. Biol. Chem. 274:8506-8515.
97. Montaner, S., R. Perona, L. Saniger, and J. C. Lacal. 1998. Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases. J. Biol. Chem. 273:12779-12785.
98. Morita, H., T. Tahara, A. Matsumoto, T. Kato, H. Miyazaki, and H. Ohashi. 1996. Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation. FEBS Lett. 395:228-234.
99. Movilla, N., and X. R. Bustelo. 1999. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol. Cell. Biol. 19:7870-7885.
100. Mu, S. X., M. Xia, G. Elliott, J. Bogenberger, S. Swift, L. Bennett, D. L. Lappinga, R. Hecht, R. Lee, and C. J. Saris. 1995. Megakaryocyte growth and development factor and interleukin-3 induce patterns of protein-tyrosine phosphorylation that correlate with dominant differentiation over proliferation of mpl-transfected 32D cells. Blood 86:4532-4543.
101. Musci, M. A., D. G. Motto, S. E. Ross, N. Fang, and G. A. Koretzky. 1997. Three domains of SLP-76 are required for its optimal function in a T cell line. J. Immunol. 159:1639-1647.
102. Nagata, Y., and K. Todokoro. 1995. Thrombopoietin induces activation of at least two distinct signaling pathways. FEBS Lett. 377:497-501.
103. Nimnual, A. S., B. A. Yatsula, and D. Bar-Sagi. 1998. Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science 279:560-563.
104. Nunes, J. A., Y. Collette, A. Truneh, D. Olive, and D. A. Cantrell. 1994. The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras. J. Exp. Med. 180:1067-1076.
105. Okumura, K., Y. Kaneko, K. Nonoguchi, H. Nishiyama, H. Yokoi, T. Higuchi, K. Itoh, O. Yoshida, T. Miki, and J. Fujita. 1997. Expression of a novel isoform of Vav, Vav-T, containing a single Src homology 3 domain in murine testicular germ cells. Oncogene 14:713-720.
106. Olson, M. F., N. G. Pasteris, J. L. Gorski, and A. Hall. 1996. Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases. Curr. Biol. 6:1628-1633.
107. Onodera, H., D. G. Motto, G. A. Koretzky, and D. M. Rothstein. 1996. Differential regulation of activation-induced tyrosine phosphorylation and recruitment of SLP-76 to Vav by distinct isoforms of the CD45 protein-tyrosine phosphatase. J. Biol. Chem. 271:22225-22230.
108. O'Rourke, L. M., R. Tooze, M. Turner, D. M. Sandoval, R. H. Carter, V. L. Tybulewicz, and D. T. Fearon. 1998. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 8:635-645.
109. Ota, Y., and L. E. Samelson. 1997. The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase. Science 276:418-420.
110. Padmore, L., S. An, R. H. Gunby, K. Kelly, G. K. Radda, and K. A. Knox. 1997. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line. Cell. Immunol. 177:119-128.
111. Pandey, A., A. V. Podtelejnikov, B. Blagoev, X. R. Bustelo, M. Mann, and H. F. Lodish. Analysis of signaling complexes by mass spectrometry: identification of Vav-2 as a novel substrate of the epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA, in press.
112. Pani, G., K. D. Fischer, I. Mlinaric-Rascan, and K. A. Siminovitch. 1996. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J. Exp. Med. 184:839-852.
113. Pasteris, N. G., A. Cadle, L. J. Logie, M. E. Porteous, C. E. Schwartz, R. E. Stevenson, T. W. Glover, R. S. Wilroy, and J. L. Gorski. 1994. Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: a putative Rho/Rac guanine nucleotide exchange factor. Cell 79:669-678.
114. Pawson, T., and T. M. Saxton. 1999. Signaling networks - do all roads lead to the same genes? Cell 97:675-678.
115. Pedraza-Alva, G., L. B. Merida, S. J. Burakoff, and Y. Rosenstein. 1998. T cell activation through the CD43 molecule leads to Vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation. J. Biol. Chem. 273:14218-14224.
116. Penninger, J. M., K. D. Fischer, T. Sasaki, I. Kozieradzki, J. Le, K. Tedford, K. Bachmaier, P. S. Ohashi, and M. F. Bachmann. 1999. The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulation. Eur. J. Immunol. 29:1709-1718.
117. Penninger, J. M., and T. W. Mak. 1998. Thymocyte selection in Vav and IRF-1 gene-deficient mice. Immunol. Rev. 165:149-166.
118. Pivniouk, V., E. Tsitsikov, P. Swinton, G. Rathbun, F. W. Alt, and R. S. Geha. 1998. Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76. Cell 94:229-238.
119. Platanias, L. C., and M. E. Sweet. 1994. Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. J. Biol. Chem. 269:3143-3146.
120. Raab, M., A. J. da Silva, P. R. Findell, and C. E. Rudd. 1997. Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2. Immunity 6:155-164.
121. Ramos-Morales, F., B. J. Druker, and S. Fischer. 1994. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. Oncogene 9:1917-1923.
122. Ramos-Morales, F., F. Romero, F. Schweighoffer, G. Bismuth, J. Camonis, M. Tortolero, and S. Fischer. 1995. The proline-rich region of Vav binds to Grb2 and Grb3-3. Oncogene 11:1665-1669.
123. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707-747.
124. Ren, X. D., and M. A. Schwartz. 1998. Regulation of inositol lipid kinases by Rho and Rac. Curr. Opin. Genet. Dev. 8:63-67.
125. Roberts, A. W., C. Kim, L. Zhen, J. B. Lowe, R. Kapur, B. Petryniak, A. Spaetti, J. D. Pollock, J. B. Borneo, G. B. Bradford, S. J. Alkinson, M. C. Dinauer, and D. A. Williams. 1999. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 10:183-196.
126. Romero, F., and S. Fischer. 1996. Structure and function of vav. Cell Signal 8:545-553.
127. Rottapel, R., C. W. Turck, N. Casteran, X. Liu, D. Birnbaum, T. Pawson, and P. Dubreuil. 1994. Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase. Oncogene 9:1755-1765.
128. Rudd, C. E. 1999. Adaptors and molecular scaffolds in immune cell signaling. Cell 96:5-8.
129. Salojin, K. V., J. Zhang, and T. L. Delovitch. 1999. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway. J. Immunol. 163:844-853.
130. Sasaki, K., H. Odai, Y. Hanazono, H. Ueno, S. Ogawa, W. Y. Langdon, T. Tanaka, K. Miyagawa, K. Mitani, Y. Yazaki, et al. 1995. TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules. Biochem. Biophys. Res. Commun. 216:338-347.
131. Sato, S., P. J. Jansen, and T. F. Tedder. 1997. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling. Proc. Natl. Acad. Sci. USA 94:13158-13162.
132. Sato, S., T. Katagiri, S. Takaki, Y. Kikuchi, Y. Hitoshi, S. Yonehara, S. Tsukada, D. Kitamura, T. Watanabe, O. Witte, et al. 1994. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J. Exp. Med. 180:2101-2111.
133. Schaeffer, H. J., and M. J. Weber. 1999. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19:2435-2444.
134. Schuebel, K. E., X. R. Bustelo, D. A. Nielsen, B. J. Song, M. Barbacid, D. Goldman, and I. J. Lee. 1996. Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes. Oncogene 13:363-371.
135. Schuebel, K. E., N. Movilla, J. L. Rosa, and X. R. Bustelo. 1998. Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J. 17:6608-6621.
136. Smyth, L. A., O. Williams, R. D. Huby, T. Norton, O. Acuto, S. C. Ley, and D. Kioussis. 1998. Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes. Proc. Natl. Acad. Sci. USA 95:8193-8198.
137. Song, J. S., J. Gomez, L. F. Stancato, and J. Rivera. 1996. Association of a p95 Vav-containing signaling complex with the FcepsilonRI gamma chain in the RBL-2H3 mast cell line. Evidence for a constitutive in vivo association of Vav with Grb2, Raf-1, and ERK2 in an active complex. J. Biol. Chem. 271:26962-26970.
138. Song, J. S., H. Haleem-Smith, R. Arudchandran, J. Gomez, P. M. Scott, J. F. Mill, T. H. Tan, and J. Rivera. 1999. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway. J. Immunol. 163:802-810.
139. Songyang, Z., S. E. Shoelson, J. McGlade, P. Olivier, T. Pawson, X. R. Bustelo, M. Barbacid, H. Sabe, H. Hanafusa, T. Yi, et al. 1994. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14:2777-2785.
140. Sotiropoulos, A., D. Gineitis, J. Copeland, and R. Treisman. 1999. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98:159-169.
141. Stradal, T., W. Kranewitter, S. J. Winder, and M. Gimona. 1998. CH domains revisited. FEBS Lett. 431:134-137.
142. Sugihara, K., N. Nakatsuji, K. Nakamura, K. Nakao, R. Hashimoto, H. Otani, H. Sakagami, H. Kondo, S. Nozawa, A. Aiba, and M. Katsuki. 1998. Rac1 is required for the formation of three germ layers during gastrulation. Oncogene 17:3427-3433.
143. Suwa, H., G. Ohshio, T. Imamura, G. Watanabe, S. Arii, M. Imamura, S. Narumiya, H. Hiai, and M. Fukumoto. 1998. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br. J. Cancer 77:147-152.
144. Symons, M., J. M. Derry, B. Karlak, S. Jiang, V. Lemahieu, F. McCormick, U. Francke, and A. Abo. 1996. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84:723-734.
145. Tarakhovsky, A., M. Turner, S. Schaal, P. J. Mee, L. P. Duddy, K. Rajewsky, and V. L. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374:467-470.
146. Teramoto, H., P. Salem, K. C. Robbins, X. R. Bustelo, and J. S. Gutkind. 1997. Tyrosine phosphorylation of the vav proto-oncogene product links FcεRI to the Racl-JNK pathway. J. Biol. Chem. 272:10751-10755.
147. Thien, C. B., and W. Y. Langdon. 1998. c-Cbl: a regulator of T cell receptor-mediated signalling. Immunol. Cell Biol. 76:473-482.
148. Treisman, R. 1994. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4:96-101.
149. vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J. Exp. Med. 184: 1161-1166.
150. Turner, M., P. J. Mee, A. E. Walters, M. E. Quinn, A. L. Mellor, R. Zamoyska, and V. L. Tybulewicz. 1997. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 7:451-460.
151. Uddin, S., S. Katzav, M. F. White, and L. C. Platanias. 1995. Insulin-dependent tyrosine phosphorylation of the vav protooncogene product in cells of hematopoietic origin. J. Biol. Chem. 270:7712-7716.
152. Uddin, S., A. Yetter, S. Katzav, C. Hofmann, M. F. White, and L. C. Platanias. 1996. Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product. Exp. Hematol. 24:622-627.
153. Van Aelst, L., and C. D'Souza-Schorey. 1997. Rho GTPases and signaling networks. Genes Dev. 11:2295-2322.
154. Weng, W. K., L. Jarvis, and T. W. LeBien. 1994. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269:32514-32521.
155. Wilson, R., R. Ainscough, K. Anderson, C. Baynes, M. Berks, J. Bonfleld, J. Burton, M. Connell, T. Copsey, J. Cooper, et al. 1994. 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature 368: 32-38.
156. vav activity. Mol. Cell. Biol. 15:4337-4346.
157. Wu, J., D. G. Motto, G. A. Koretzky, and A. Weiss. 1996. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 4:593-602.
158. Wu, J., Q. Zhao, T. Kurosaki, and A. Weiss. 1997. The Vav binding site (Y315) in ZAP-70 is critical for antigen receptor-mediated signal transduction. J. Exp. Med. 185:1877-1882.
159. Xavier, R., T. Brennan, Q. Li, C. McCormack, and B. Seed. 1998. Membrane compartmentation is required for efficient T cell activation. Immunity 8:723-732.
160. Xu, X., and A. S. Chong. 1996. Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase. Biochem. J. 318:527-532.
161. Yablonski, D., M. R. Kuhne, T. Kadlecek, and A. Weiss. 1998 Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell. Science 281:413-416.
162. Ye, Z. S., and D. Baltimore. 1994. Binding of Vav to Grb2 through dimerization of Src homology 3 domains. Proc. Natl. Acad Sci. USA 91:12629-12633.
163. Yeung, Y. G., Y. Wang, D. B. Einstein, P. S. Lee, and E. R. Stanley. 1998. Colony-stimulating factor-1 stimulates the formation of multimeric cytosolic complexes of signaling proteins and cytoskeletal components in macrophages. J. Biol. Chem. 273:17128-17137.
164. Yuo, A., S. Kitagawa, S. Iki, M. Yagisawa, E. K. Inuo, T. Mimura, S. Minoda, Y. Hanazono, H. Hirai, A. Urabe, et al. 1995. Tyrosine phosphorylation of vav protooncogene product in primary human myelogenous leukemic cells stimulated by granulocyte colony-stimulating factor. Biochem. Biophys. Res. Commun. 211:677-685.
165. Zhang, R., F. W. Alt, L. Davidson, S. H. Orkin, and W. Swat. 1995. Defective signalling through the T-and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470-473.
166. Zhang, R., F. Y. Tsai, and S. H. Orkin. 1994. Hematopoietic development of vav-/-mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 91: 12755-12759.
167. Zhang, W., B. J. Irvin, R. P. Trible, R. T. Abraham, and L. E. Samelson. 1999. Functional analysis of LAT in TCR-mediated signaling pathways using a LAT-deficient Jurkat cell line. Int. Immunol. 11:943-950.
168. Zhang, W., J. Sloan-Lancaster, J. Kitchen, R. P. Trible, and L. E. Samelson. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92:83-92.
169. Zhang, W., C. L. Sommers, D. N. Burshtyn, C. C. Stebbins, J. B. DeJarnette, R. P. Trible, A. Grinberg, H. C. Tsay, H. M. Jacobs, C. M. Kessler, E. O. Long, P. E. Love, and L. E. Samelson. 1999. Essential role of LAT in T cell development. Immunity 10:323-332.
170. Zhang, W., R. P. Trible, and L. E. Samelson. 1998. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 9:239-246.
171. Zhao, Q., B. L. Williams, R. T. Abraham, and A. Weiss. 1999. Interdomain B in ZAP-70 regulates but is not required for ZAP-70 signaling function in lymphocytes. Mol. Cell. Biol. 19:948-956.
172. Zohn, I. M., S. L. Campbell, R. Khosravi-Far, K. L. Rossman, and C. J. Der. 1998. Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene 17:1415-1438.